Covenant Multifamily Offices’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$2.88M Sell
68,081
-4,119
-6% -$182K 0.52% 30
2021
Q2
$2.83M Buy
72,200
+57,248
+383% +$2.23M 0.51% 32
2021
Q1
$542K Buy
14,952
+4,594
+44% +$163K 0.11% 103
2020
Q4
$381K Sell
10,358
-778
-7% -$28.5K 0.07% 95
2020
Q3
$388K Sell
11,136
-1,026
-8% -$36K 0.08% 82
2020
Q2
$377K Sell
12,162
-23,237
-66% -$789K 0.07% 107
2020
Q1
$1.1M Sell
35,399
-27,755
-44% -$946K 0.28% 46
2019
Q4
$2.89M Buy
63,154
+28,980
+85% +$1.03M 0.49% 34
2019
Q3
$1.17M Buy
34,174
+2,562
+8% +$93.2K 0.25% 61
2019
Q2
$1.3M Buy
+31,612
New +$1.26M 0.28% 56

Other funds holding PFE

Covenant Multifamily Offices's PFE Position: Q3 2021 in Review

Covenant Multifamily Offices reduced its Pfizer (PFE) stake by 5.7% in Q3 2021, selling an estimated $182K and leaving 68,081 shares worth $2.88M. The position accounts for 0.52% of the portfolio, ranked #30.

Covenant Multifamily Offices first reported a position in PFE in Q2 2019 and has held it in 10 quarters since. The position peaked at $2.89M in Q4 2019. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • Covenant Multifamily Offices held 68,081 shares of Pfizer worth $2.88M as of Q3 2021.
  • Covenant Multifamily Offices sold 4,119 Pfizer shares in Q3 2021, an estimated $182K.
  • Pfizer made up 0.52% of Covenant Multifamily Offices's portfolio in Q3 2021, its #30 holding.
  • Covenant Multifamily Offices first reported a position in Pfizer in Q2 2019 and has held it in 10 quarters since.
  • Covenant Multifamily Offices's Pfizer position peaked at $2.89M in Q4 2019.
  • 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Covenant Multifamily Offices's 13F filing for Q3 2021, filed 21 Oct 2021.